PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study

PerZeption Inc. received a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute for a project focused on efficient achromatic and chromatic photostress recovery assessment for age-related macular degeneration. The announcement supports early-stage development of the company's ophthalmic assessment technology, though no grant amount or commercialization timeline was disclosed.